Canada purchases 500,000 human H5N1 vaccine doses

Canada purchased half a million doses of a human vaccine for high path avian flu. It is an effort to keep health risks at bay.

Last week an outbreak was reported in a backyard layer poultry farm in Canada.
One infectious disease expert warns with so many cases of seasonal flu popping up, it is likely the two viruses could mix. That would ultimately create a new virus.

According to Matthew Miller, “That process is how all prior flu pandemics, that we’re aware of in the past, have started. Two different influenza viruses infect one host. The avian flu might maintain the severe disease that it causes but gain the ability to spread well between humans the way that seasonal flu can.”

Canada’s Public Health Agency says that risks to the public are still low, but they warn that it is best to stay away from poultry flocks this flu season.

Related Stories
Fertilizer still consumes an unusually large share of crop value.
Pollination costs remain volatile, raising planning risk for specialty crop producers.
Kerry Hartwig from Sukup Manufacturing previews the grain management solutions they plan to share with producers at the upcoming Commodity Classic in San Antonio.
FBN co-founder Charles Baron previews the upcoming Farmer2Farmer event and how technology and AI are shaping the industry, offering growers practical insights and farmer-led strategies for modern agriculture.
The USDA Agricultural Outlook Forum highlights modest price support from tighter supplies across cotton, grains, dairy, livestock, and sugar into 2026.
Farm Bureau Economist Faith Parum discusses the latest Farm Bill proposal and the path ahead for Congress and U.S. agriculture.